AMGEN INC (AMGN) revenue & profit
AMGEN INC (AMGN): revenue $36.8B, net income $7.7B in 2025; latest quarter +9.5% year over year. From SEC filings.
$36.8BRevenue 2025
TickerAMGN (Nasdaq)
IndustryHealthcare · Biological Products, (No Diagnostic Substances)
Revenue 2025$36.8B
Net income 2025$7.7B
Net margin21%
Annual revenue growth+10%
Latest quarter (2026 Q2) · Revenue$10.1B
vs. same quarter last year+9.5%
Latest quarter · Net income$2.4B
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $26.3B | $6.6B | |
| 2023 | $28.2B | $6.7B | |
| 2024 | $33.4B | $4.1B | |
| 2025 | $36.8B | $7.7B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.